WeVote
Log In

Bill

Bill

HB 252

Pharmacists; authorize to test for and administer treatment for minor, nonchronic health conditions.

2025 Regular Session Introduced by Lee Yancey

Mississippi bill would have authorized pharmacists to independently test for and treat minor, nonchronic conditions, but died in committee.

Died In Committee
#publichealthandhumanservices
0
WeVote Research Nonpartisan
Bill Summary · HB 252

Legislative bill overview

HB 252 would have expanded the scope of practice for pharmacists in Mississippi to allow them to test for and treat minor, nonchronic health conditions without requiring a physician's direct involvement. The bill died in committee on February 4, 2025, after being referred to the Public Health and Human Services Committee in January.

Why is this important

Pharmacists are already accessible healthcare providers in most communities, and expanding their authority could improve access to care for minor ailments while potentially reducing unnecessary emergency room visits and physician office appointments. However, this touches on fundamental questions about professional licensing boundaries, patient safety oversight, and the extent of pharmacist training compared to other healthcare providers.

Potential points of contention

  • Scope creep concerns: Defining "minor, nonchronic" conditions is subjective; conditions that seem minor may have serious underlying causes requiring physician diagnosis
  • Training and liability: Opponents may argue pharmacists lack sufficient clinical training for independent diagnosis and treatment decisions compared to nurse practitioners or physician assistants with similar expanded authority
  • Insurance and oversight: Questions about how treatments would be billed, what accountability mechanisms exist, and whether pharmacist-administered care would be covered by insurance

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.